Sign in

CIK 0001326732 · Accelerated filer

Ticker
XNCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
201622502
Phone
626-305-5900
Business address
465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,591,617
in 2 filings

Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-05 Valente Nancy EVP, Chief Development Officer Grant or award +19,634 59,860
2024-03-05 Valente Nancy EVP, Chief Development Officer Grant or award · Stock Options +117,801 117,801
2024-03-05 Kuch John J SR. VICE PRESIDENT & CFO Sale −4,474 $23.43 $105K 121,919
2024-03-05 Desjarlais John R SR. VICE PRESIDENT & CSO Sale −6,629 $23.43 $155K 166,989
2024-03-05 Desjarlais John R SR. VICE PRESIDENT & CSO Grant or award +20,724 187,713
2024-03-05 Desjarlais John R SR. VICE PRESIDENT & CSO Grant or award · Stock Options +124,346 124,346
2024-03-05 Eckert Celia SVP, GENERAL COUNSEL Sale −3,892 $23.43 $91K 33,226
2024-03-05 Eckert Celia SVP, GENERAL COUNSEL Grant or award +13,089 46,315
2024-03-05 Eckert Celia SVP, GENERAL COUNSEL Grant or award · Stock Options +78,534 78,534
2024-03-05 Dahiyat Bassil I PRESIDENT & CEO Sale −12,528 $23.43 $294K 300,097
2024-03-05 Dahiyat Bassil I PRESIDENT & CEO Grant or award +54,538 354,635
2024-03-05 Dahiyat Bassil I PRESIDENT & CEO Grant or award · Stock Options +327,225 327,225
2024-02-14 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise +11,943 $11.05 $132K 173,618
2024-02-14 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise · Stock Option (Right to Buy) −11,943 0
2024-02-13 GORMAN KEVIN CHARLES Director Purchase +53 $19.12 $1K 5,060
2024-02-13 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise +68,057 $11.05 $752K 215,783
2024-02-13 Desjarlais John R SR. VICE PRESIDENT & CSO Sale −54,108 $19.38 $1.0M 161,675
2024-02-13 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise · Stock Option (Right to Buy) −68,057 11,943
2023-12-29 Dahiyat Bassil I PRESIDENT & CEO Option exercise +65,001 $11.05 $718K 357,929
2023-12-29 Dahiyat Bassil I PRESIDENT & CEO Sale −45,000 $20.93 $942K 312,929

Page 9 of 11 · 211 trades